A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014)

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

February 6, 2019

Primary Completion Date

March 18, 2023

Study Completion Date

April 6, 2023

Conditions
Gram-Positive Infections
Interventions
DRUG

IV Tedizolid Phosphate

A single dose, or twice daily dose for 3 days, of tedizolid phosphate administered IV.

DRUG

Oral Suspension Tedizolid Phosphate

A single dose of tedizolid phosphate administered as an oral suspension.

Trial Locations (30)

1478

Akershus Universitetssykehus HF ( Site 1604), Loerenskog

3320

MHAT Sv. Ivan Rilski EOOD ( Site 2201), Kozloduy

3400

"MHAT Dr. Stamen Iliev Montana ( Site 2215)", Montana

MHAT City Clinic Sv. Georgi EOOD ( Site 2202), Montana

4011

Stavanger Universitetssykehus, Helse Stavanger ( Site 1601), Stavanger

5021

Haukeland Universitetssjukehus ( Site 1602), Bergen

5300

MHAT Dr. Tota Venkova-Pediatrics ( Site 2218), Gabrovo

5400

Medical Center - 1- Sevlievo EOOD ( Site 2207), Sevlievo

5800

UMHAT Dr. Georgi Stranski EAD ( Site 2211), Pleven

7002

MHAT Rousse-Neonatology ( Site 2213), Rousse

Multiprofile Hospital for Active Treatment - Ruse ( Site 2204), Rousse

UMHAT Kanev AD ( Site 2209), Rousse

7006

St. Olavs Hospital. ( Site 1600), Trondheim

8127

UMHAT Deva Maria ( Site 2208), Burgas

8800

MHAT Dr. Ival Seliminski ( Site 2212), Sliven

60611

Ann & Robert H. Lurie Children's Hospital of Chicago ( Site 1022), Chicago

63110

Saint Louis Children's Hospital ( Site 1020), St Louis

70808

Our Lady of the Lake Regional Medical Center. ( Site 1004), Baton Rouge

72202

Arkansas Children's Hospital ( Site 1012), Little Rock

84113

Primary Children's Hospital ( Site 1000), Salt Lake City

92123

Sharp Memorial Hospital ( Site 1021), San Diego

92868

Children's Hospital of Orange County ( Site 1001), Orange

111221

Fundacion Hospital Infantil Universitario de San Jose ( Site 1107), Bogotá

760032

Fundacion Valle del Lili ( Site 1102), Santiago de Cali

050010

Hospital San Vicente Fundacion ( Site 1103), Medellín

080020

Clinica de la Costa S.A.S. ( Site 1106), Barranquilla

SO16 6YD

University Hospital Southampton NHS Foundation Trust ( Site 1700), Southampton

L12 2AP

Alder Hey Childrens NHS Foundation Trust Hospital ( Site 1703), Liverpool

NE1 4LP

Royal Victoria Infirmary ( Site 1702), Newcastle

OX3 9DU

Oxford University Hospitals NHS Foundation Trust ( Site 1704), Oxford

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT03217565 - A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014) | Biotech Hunter | Biotech Hunter